About 1,472,100 results (2,773 milliseconds)

US9382304B2 - Engineered polypeptides having enhanced ...

https://patents.google.com/patent/US9382304B2/en
Yet further examples of exendin analogs suitable for use in the engineered polypeptide constructs are those described in published PCT application WO/2010/ ...

WO2013148966A1 - Transmucosal delivery of engineered ...

https://patents.google.com/patent/WO2013148966A1/en
[0065] Further examples of exendin analogs suitable for use in the engineered polypeptide constructs are those described in published PCT application ...

EP2729481B1 - Engineered polypeptides having enhanced ...

https://patents.google.com/patent/EP2729481B1/en
The present application relates to compounds having good duration of action, high potency and/or convenient dosing regimens, including oral administration, ...

US20150133373A1 - Transmucosal delivery of engineered ...

https://patents.google.com/patent/US20150133373A1/en
... Application filed by AstraZeneca Pharmaceuticals LP filed Critical ... solution Substances 0.000 description 15; 108020004414 DNA Proteins 0.000 ...

CN102348715A - Extended recombinant polypeptides and ...

https://patents.google.com/patent/CN102348715A/en
6,806,063 is said with U.S. Patent application No.20080261886. On the one hand, the present invention provides the monomers B PXTEN fusion rotein of FIX, ...

CA3064363A1 - Non-small cell lung cancer biomarkers and uses ...

https://patents.google.com/patent/CA3064363A1/en
The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of non-small cell lung cancer and ...

US10864268B2 - CD47 antibodies, methods, and uses - Google ...

https://patents.google.com/patent/US10864268B2/en
Moreover, in therapeutic applications of monoclonal antibodies, it is important to identify antibodies having a high degree of specificity and a high binding ...

US8883714B2 - Pharmaceutical compositions comprising GPR119 ...

https://patents.google.com/patent/US8883714B2/en
... SDS or with 0.2×SSC/0.1% SDS. In some embodiments, a GPCR that may be ... kit manufacturer's instructions. The fluorescence ratio of the samples (test ...

EP4358995A1 - A myostatin pathway inhibitor in combination with a ...

https://patents.google.com/patent/EP4358995A1/en
[2] The instant application relates to use of myostatin pathway inhibitors and GLP-1 pathway activators for treating and maintaining metabolic disorders, ...

EP1033405A2 - Sequence-determined DNA fragments and ...

https://patents.google.com/patent/EP1033405A2/en
... window, where the fragment of the polynucleotide or amino acid sequence in the comparison window may comprise additions or deletions (e.g., gaps or ...

CN104271588A - 具有增强的作用持续时间和降低的免疫原性的工程 ...

https://patents.google.com/patent/CN104271588A/zh
... (Gila monster)和墨西哥鬃狮蜥(Mexican Bearded Lizard)的唾液分泌物中发现的肽 ... SDS的凝胶运行缓冲液中电洗脱。如果GST/工程改造的多肽的融合蛋白在细菌中作为 ...